indazoles has been researched along with mifepristone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benakanakere, I; Besch-Williford, C; Carroll, CE; Hyder, SM; Liang, Y | 1 |
| Chai, X; Chen, H; Duan, M; Fu, W; Hou, T; Hu, X; Kang, Y; Li, D; Pang, J; Shen, C; Wang, E; Wang, X; Xia, H; Xu, L; Zhang, J | 1 |
2 other study(ies) available for indazoles and mifepristone
| Article | Year |
|---|---|
The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development.
Topics: Animals; Anthracenes; Apoptosis; Blotting, Western; Cell Proliferation; Enzyme Activators; Enzyme-Linked Immunosorbent Assay; Female; Guanylate Cyclase; Hormone Antagonists; Humans; Immunoenzyme Techniques; Indazoles; Mammary Neoplasms, Animal; Mice; Mice, Nude; Mifepristone; Piperidines; Progestins; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2013 |
Discovery of Novel GR Ligands toward Druggable GR Antagonist Conformations Identified by MD Simulations and Markov State Model Analysis.
Topics: Dexamethasone; Humans; Indazoles; Ligands; Markov Chains; Mifepristone; Molecular Dynamics Simulation; Pyridines; Receptors, Glucocorticoid | 2022 |